Page 4 line 13. Bristol stool form scale was not used for diagnosis of constipation? the authors did not include this method in the diagnostic criteria.
Page 4 line 44. Spontaneous bowel movement (SBM) was the only one primary outcome defined in this study, but in some other studies, such as the Cochrane review the authors mentioned in the introduction section, they also included pain or straining on defecation, Incidence of postpartum constipation and some other outcomes as primary outcomes. are there some special reasons for that in this study?
Page 5 line 15. Why the Wanfang data is not included in searching sources? As we know that quite a lot high quality of Chinese journals from Chinese medical association, only included in Wangfang database since 1998.
Page 5 line 24. I think it would be better to include the detailed search strategies about other databases in appendix 1, not just PubMed. 
REVIEWER
Raffaele Capasso University of Naples Federico II REVIEW RETURNED 30-Jul-2018 
GENERAL COMMENTS

The protocol of Zhai et al. is about the preparation of a systematic review for the therapeutic use of Chinese herbal medicine in case of postpartum constipation. The authors plan to review all the scientific papers that have been published about this issue since 1900. They do not want to restrict the search by any way. Although the postpartum constipation is a relevant clinical problem I feel that this proposal has several weaknesses: 1. The search without restriction is risky, because if they find any paper in any language even from the beginning of the previous century, the justification of the correctness of data will be more the questionable. 2. I have made a quick search in PubMed with the key words "postpartum, constipation, herbal" or "postpartum, constipation, Chinese medicine", and only few (max. 5) paper has been found. I think it is a sign, that the reliable amount of studies in this topic is very low. 3. Based on point 2, I cannot see real chance to find relevant data that helps to understand the differences in herbal therapy for constipation caused by different reasons during the postpartum period. 4. The authors have not considered a major risk in their protocol: how the herbal medicine can influence the mother's milk production and how the herbal drugs reduce the possibility of healthy lactation that is essential for new-borns and infants. 
REVIEWER
GENERAL COMMENTS
I am not sure of the guidelines from the journal but as this is simply the protocol for the systematic review and presents no findings, I am not sure of the relevance. It is clearly written with appropriate proposed methodology but would be more interesting to see the findings.
REVIEWER
Feng Yibin The University of Hong Kong
REVIEW RETURNED
16-Oct-2018
GENERAL COMMENTS
This protocol aims to conduct a systematic review and metaanalysis to evaluate the efficacy and safety of CHM for postpartum constipation. It should be of great interest to readers and important for enhancing quality of life of postpartum women. However, a few specific issues the authors should address by making modifications to the protocol or by clarifying in their response, after which I would consider this protocol suitable for publication in BMJ open. Comments: 1. Introduction: authors mentioned "quite a few clinical trials found CHM could have a role to play in the management of postpartum constipation", here meant only quite a few clinical trials had been conducted or quite a lot of clinical trials had been performed but only quite a few clinical trials found CHM could have a role? 2. Types of studies: if a study described it was a randomized controlled trial without reporting randomization method, will the study be considered as randomized controlled trial and included in the review? 3. Types of participants: please introduce the diagnostic criteria of constipation. focused on the effectiveness of interventions for treating postpartum constipation in which no RCTs were actually included. In this study, we focused on Chinese herbal medicine for treating postpartum constipation so that we have made no changes.
Methods
Page 3 line 51. The abbreviations should be used at the first place when you used them, you mentioned RTCs in the inductions, here it is not the first time mentioned, please change that and check other abbreviations. Response: Thank you for your suggestions. We have checked abbreviations and made the advised changes. Page 4 line 44. Spontaneous bowel movement (SBM) was the only one primary outcome defined in this study, but in some other studies, such as the Cochrane review the authors mentioned in the introduction section, they also included pain or straining on defecation, Incidence of postpartum constipation and some other outcomes as primary outcomes. are there some special reasons for that in this study? Response: Thank you for your suggestions. This study focuses on the treatment of postpartum constipation. Therefore, the incidence of postpartum constipation is not considered as the primary outcome. We know that more than one outcome is considered the primary outcome in some previous systematic reviews. When multiple outcome comparisons are included and review authors are free to choose and highlight single results among the many comparisons, there will be an increased risk of false declaration on the effectiveness of an assessed intervention (Jakobsen JC, Wetterslev J, Winkel P, et al. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014 Nov 21;14:120). Besides, SBM is selected as the primary outcome in many trials investigating the effectiveness of interventions for constipation. So SBM is considered as the only one primary outcome in this study. And some other indicators are considered as secondary outcomes.
Page 5 line 15. Why the Wanfang data is not included in searching sources? As we know that quite a lot high quality of Chinese journals from Chinese medical association, only included in Wangfang database since 1998. Response: Thank you for your suggestions. We have included Wanfang data in searching sources in the section of 'Electronic searches'.
Page 5 line 24. I think it would be better to include the detailed search strategies about other databases in appendix 1, not just PubMed. Response: Thank you for your suggestions. We have made the advised changes in appendix 1. Although the postpartum constipation is a relevant clinical problem I feel that this proposal has several weaknesses: 1. The search without restriction is risky, because if they find any paper in any language even from the beginning of the previous century, the justification of the correctness of data will be more the questionable. Response: Thank you for your suggestions. A systematic review attempts to collate all evidence that fits prespecified eligibility criteria in order to answer a specific research question. Therefore, no language or publication date will be restricted. However, language and publication date may account for the between-study variability. So we will contact authors of included studies for providing further details or clarification whenever possible. Moreover, subgroup analyses will be used to explore possible sources of heterogeneity based on language or publication date. We have made the advised changes in the section of 'Subgroup analysis and investigation of heterogeneity'.
2. I have made a quick search in PubMed with the key words "postpartum, constipation, herbal" or "postpartum, constipation, Chinese medicine", and only few (max. 5) paper has been found. I think it is a sign, that the reliable amount of studies in this topic is very low. Response: Thank you for your suggestions. To our knowledge, many trials about Chinese herbal medicine for postpartum constipation have been indexed by Chinese medical databases but not by PubMed. A previous search in Chinese medical databases conducted by us showed that more than 10 reports met our inclusion criteria. In the future, the comprehensive search will be conducted to identify potentially other eligible studies. Therefore, we think that this study can provide valuable information for clincial practice.
3. Based on point 2, I cannot see real chance to find relevant data that helps to understand the differences in herbal therapy for constipation caused by different reasons during the postpartum period.
Response: Thank you for your suggestions. Based on the response to point 2, we still have the chance to find relevant data that helps to understand the differences in herbal therapy for constipation caused by different reasons during the postpartum period. The subgroup analyses will be used to explore the differences based on the aetiology of postpartum constipation. We have made the advised changes in the section of 'Subgroup analysis and investigation of heterogeneity'.
